# C_2009025EN.01002701.xml

| 31.1.2009 | EN | Official Journal of the European Union | C 25/27 |
| --- | --- | --- | --- |

31.1.2009

EN

Official Journal of the European Union

C 25/27

---

Prior notification of a concentration

(Case COMP/M.5448 — Abbott/Advanced Medical Optics)

Candidate case for simplified procedure

(Text with EEA relevance)

(2009/C 25/05)

| 1. | On 19 January 2009, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking Abbott Laboratories (‘Abbott’, USA) acquires, within the meaning of Article 3(1)(b) of the Council Regulation, control of the whole of the undertaking Advanced Medical Optics, Inc. (‘AMO’, USA), by way of a public bid. |
| --- | --- |

1.

On 19 January 2009, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking Abbott Laboratories (‘Abbott’, USA) acquires, within the meaning of Article 3(1)(b) of the Council Regulation, control of the whole of the undertaking Advanced Medical Optics, Inc. (‘AMO’, USA), by way of a public bid.

1

| 2. | The business activities of the undertakings concerned are:






  — | for Abbott: discovery, development, manufacture and sale of a broadly diversified line of health care products, |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

for Abbott: discovery, development, manufacture and sale of a broadly diversified line of health care products,

| — | for AMO: the discovery, development, manufacture and sale of eye health care (but no other health care) products. |
| --- | --- |

—

for AMO: the discovery, development, manufacture and sale of eye health care (but no other health care) products.

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

2

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax ((32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.5448 — Abbott/Advanced Medical Optics, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition |
| Merger Registry |
| J-70 |
| B-1049 Brussels |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax ((32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.5448 — Abbott/Advanced Medical Optics, to the following address:

European Commission

Directorate-General for Competition

Merger Registry

J-70

B-1049 Brussels

---

(1)  OJ L 24, 29.1.2004, p. 1.

1

(2)  OJ C 56, 5.3.2005, p. 32.

2

---